ASEAN Veterinary Rabies Vaccines Market Size & Share 2025 – 2034

ASEAN Veterinary Rabies Vaccines Market Size

The ASEAN veterinary rabies vaccines market was valued at USD 30.2 million in 2024 and is expected to reach USD 54.9 million by 2034, growing at a CAGR of 6.2% during 2025 to 2034. Factors such as the increasing incidence of rabies in the region and awareness of its implications on human and animal health are primary drivers for the market growth. Government initiatives directed towards rabies elimination like large scale vaccination of pets and stray dogs have greatly increased the need for veterinary rabies vaccines. Additionally, the growing pet ownership trend, coupled with increased expenditure on animal healthcare, is fostering market expansion.

The increasing occurrence of zoonotic diseases as well as the possibility of infectious outbreaks have been propelling the growth of veterinary rabies vaccines in the region. Countries such as Indonesia, the Philippines, Thailand, and Vietnam have established national rabies control programs which incorporate mass dog vaccination drives. These programs are funded by international organizations like WHO and FAO, which creates a demand for these veterinary rabies vaccines. In addition, the global strategic plan for rabies control, aimed at halting human deaths from the disease by 2030, has increased the urgency of vaccination drives throughout the region.
 

The other core driver is the increase in pet ownership and overall pet health awareness within ASEAN nations. Accompanied by urban development and an increase in disposable income, there is a growing trend in household adoptions of dogs and cats which drives the need for vaccinations, including rabies. This, along with the increased access to veterinary clinics and pet healthcare services in urban and semi-urban centers, is supporting the trend. Public educational campaigns on pet ownership and the dangers of rabies have increased the public's willingness to vaccinate companion animals and therefore increased public awareness, thus driving the demand for veterinary rabies vaccines in the region.
 

Veterinary rabies vaccines are immunological preparations specifically developed for animals for the prevention of rabies infections caused by the Rabies virus. These vaccines invoke the immune response of an animal to generate protective antibodies which will neutralize the virus, thereby preventing the onset of disease following exposure.
 

ASEAN Veterinary Rabies Vaccines Market Trends

• The increase in pet ownership trends in urban areas of Southeast Asia has resulted in a surge in demand for veterinary services, including rabies vaccination. Middle class families in the Philippines, Vietnam, and even Malaysia are now adopting cats and dogs which is leading to increased awareness of preventive healthcare services.
   
• Due to the seriousness of rabies as a public health concern, especially due to its zoonotic potential, pet owners are more motivated to have their pets vaccinated. As a result, the companion animal sector is expected to capture the most revenue growth in the market and sustain this growth due to shifting lifestyles, growing affection towards pets, and the rise of veterinary clinics that focus on caring for pets in urban areas.
   
• Moreover, the increasing prevalence of rabies cases greatly impacts the growth of the ASEAN veterinary rabies vaccines market. Rabies continues to be a major public health concern in several Southeast Asian countries. For example, the World Organization of Animal Health (WOAH) estimates that the disease causes approximately 59,000 human fatalities each year in over 150 countries, of which 95% are located in Africa and Asia.
   
• Additionally, uncontrolled populations of stray dogs in some ASEAN nations pose a public health threat, making rabies control measures an ongoing necessity. For instance, estimates suggest that there are over 100,000 stray dogs roaming the streets of major cities like Jakarta and Bali, Indonesia. Similarly, the stray animal population in Thailand is estimated to be greater than the total human population of many of the countries in the world.
   
• To combat outbreaks and prevent cross-species transmission, governments and NGOs tend to conduct targeted vaccination campaigns in identified high-risk regions. In addition, the greater development of rural livestock and animal farming also requires these animals to be vaccinated. These factors create a constant and multi-dimensional need for veterinary rabies vaccines, thus stimulating the market in the ASEAN region.
   
• Governments within ASEAN countries have taken the initiative to eliminate rabies through extensive mass vaccination programs. In alignment with global objectives set forth by the WHO and OIE to eliminate dog-transmitted rabies by 2030, countries such as Thailand, Indonesia, and Cambodia have started implementing large-scale vaccination campaigns. The robust political commitment along with public health initiatives aimed at rabies control will likely increase the veterinary rabies vaccine market within the region in coming years.
   

Trump Administration Tariffs

• The tariffs levied by the Trump Administration on China, and to some degree on a broader range of global trade partners, may place indirect strain on the ASEAN veterinary vaccines market by potentially disrupting supply chains and increasing the cost of raw materials and equipment.
   
• Several ASEAN countries depend on biotechnology components and manufacturing equipment exported from the U.S. and China. According to recent data from the ASEAN Secretariat's Economic Update (April 2025), approximately 35% of veterinary vaccine production in the region relies on imported components affected by current tariff structures, suggesting potential vulnerabilities in regional supply security. Consequently, producers operating in the ASEAN region might incur higher costs, which could lead to price inflation or even stagnant production due to reduced capacity.
   
• Furthermore, the uncertainty surrounding trade policies might compel ASEAN nations to broaden their sourcing strategies while simultaneously bolstering local manufacturing capacity. The ASEAN Economic Community (AEC) has initiated a Veterinary Products Strategic Framework 2025-2030 that aims to increase intra-ASEAN trade of veterinary biologicals by 40% over five years, potentially mitigating some impacts of external trade tensions through regional integration and collaborative research initiatives.
   
• Although this may enhance adaptive capacity to market volatility in the long run, in the short term, the market could experience instability. These factors might also shape the region's veterinary vaccine investment portfolio and market entry strategies.
   

ASEAN Veterinary Rabies Vaccines Market Analysis

Based on the animal type, the market is segmented into companion animals, livestock animals, and wildlife. The companion animals’ segment is further classified into dogs, cats, and other companion animals. The companion animals segment crossed USD 18.9 million in 2024.
 

• The companion animal segment has a considerable share in the ASEAN veterinary rabies vaccines market owing to the rising pet ownership trends across the region. The upsurge in urbanization and disposable income has resulted in the uptake of dogs and cats as household companions in Thailand, Indonesia, and the Philippines.
   
• According to a survey on pet ownership, approximately 71% of Thai respondents stated that they owned at least one pet.
   
• This high population of pets in the region, together with the rising awareness amongst pet owners about routine vaccinations to curb rabies, has increased demand.
   
• One more element that enhances the market share considerably is the involvement of private and public sector organizations in implementing vaccination programs aimed at pets to control rabies. In several ASEAN countries, there is an elimination policy for rabies, which primarily focuses on the vaccination of dogs.
   
• Furthermore, the developed ASEAN economies like Singapore and Malaysia have more veterinary service centers, which makes it easier for pet owners to have their animals vaccinated against rabies.
   
• Also, increasing adoption of pet insurance policies and pet wellness plans stimulates the demand for thorough veterinary services, including scheduled vaccinations. These sociocultural and economic dynamics bolster the companion animals' dominance in the ASEAN veterinary rabies vaccines industry.
   

Learn more about the key segments shaping this market

Download Free PDF

Based on the application, the market is categorized into pre-exposure prophylaxis and post-exposure prophylaxis. The post-exposure prophylaxis segment dominated 69.4% share of the market in 2024.
 

• The post-exposure prophylaxis (PEP) segment holds a significant market share in the ASEAN veterinary rabies vaccines market due to persistent challenges in rabies control among domestic and wild animals.
   
• Endemic rabies remains a concern in Indonesia, the Philippines, and Vietnam, where animal bite incidents, particularly from stray dogs, are common.
   
• This situation has increased the demand for rapid intervention vaccination strategies, making post-exposure prophylaxis essential for preventing rabies infection after exposure.
   
• Veterinary professionals and animal owners heavily depend on PEP protocols to protect animals following potential rabid animal encounters.
   
• Increased awareness about timely post-exposure vaccination among pet owners and veterinary professionals has strengthened the demand for PEP vaccines.
   

Based on the route of administration, the ASEAN veterinary rabies vaccines market is categorized injectable and oral. The injectable segment is projected to reach USD 45.2 million by 2034.
 

• Due to its long-standing effectiveness and wide acceptance among veterinary practitioners, the injectable segment commands a high market share in the market.
   
• Rabies vaccinations using injectable vaccines have been done successfully on both domesticated and wild animals for a long time. Vaccines are mostly given by SC or IM injection.
   
• Injectable vaccines are a preferred choice for rabies prevention in animals, especially in areas of massive rabies outbreaks because of their effectiveness in increasing and sustaining immunity.
   
• Further, the availability of various injectable vaccine products in the market tailored for different animal species contributes to its broad market appeal.
   

Based on the end use, the ASEAN veterinary rabies vaccines market is segmented into veterinary hospitals and clinics, animal shelters and rescue organizations, and research institutes. The veterinary hospitals and clinics segment dominated the market in 2024 and is anticipated to witness a growth rate of over 6.1% between 2025 - 2034.
 

• Veterinary hospitals and clinics dominate the ASEAN veterinary rabies vaccines industry due to their integral part in pet care management and disease control.
   
• Pet owners and livestock keepers often seek vaccinations at these facilities, which makes them important access points for the distribution of rabies vaccines.
   
• The integration of technology and digital health records within veterinary hospitals and clinics has further enhanced their market position. Moreover, the increasing number of veterinary hospitals and clinics further drives their segmental growth.
   
• Also, the rapidly developing infrastructure, specialized skills, and the increasing public trust and reliance on veterinary hospitals and clinics are the key drivers for their commanding market share in the ASEAN veterinary rabies vaccines industry.
   

Indonesia ASEAN veterinary rabies vaccines market experienced significant growth in 2021, 2022 and 2023 and was valued at USD 6.6 million, USD 7 million, USD 7.4 million respectively.
 

• Due to Indonesia's significant animal population and the existing rabies belts in the country, it commands a significant share of the market.
   
• With one of the largest dog populations in Southeast Asia and a huge population of stray animals, the country has been facing difficulties in curbing the spread of rabies. This particularly drives the consumption rate of rabies vaccines for pets for rabies control.
   
• Moreover, the local production of veterinary rabies vaccines by local pharmaceutical companies helps to sustain the demand at lower costs.
   

Vietnam exhibits strong growth potential in the ASEAN veterinary rabies vaccines market.
 

• Vietnam presents a high growth opportunity in the ASEAN rabies veterinary vaccines market, owing to the nation's large domestic animal population, especially in rural and suburban areas with high dog ownership.
   
• The country struggles with the threat of rabies, experiencing sporadic outbreaks that continue to endanger both human and animal health. For example, as per the WHO, rabies deaths in Vietnam surpass 70 annually, most of these deaths occurring due to rabid dog bites.
   
• To curb this, the Vietnamese government has begun to focus more on rabies control in pets through national programs aimed at increasing animal vaccination, particularly with dogs and cats. These disease management strategies have led to a steady need for veterinary rabies vaccines and created advantageous market opportunities for domestic and foreign manufacturers.
   

The Philippines is experiencing significant growth in the ASEAN veterinary rabies vaccines market.
 

• The increased demand for veterinary rabies vaccines in the Philippines is driven by the persistent public health threat rabies poses, which compels the government to make elimination a public health priority.
   
• National programs like the "Rabies-Free Philippines" initiative have increased urban and rural vaccination drives, along with increasing the wider consumption of veterinary rabies vaccines.
   
• In addition, the rising levels of pet ownership and livestock and animal owners' proactive approach towards animal healthcare further accelerates market growth.
   

ASEAN Veterinary Rabies Vaccines Market Share

The ASEAN veterinary rabies vaccines industry is highly competitive, with several key companies striving to develop novel formulations in the market. Several major organizations, local small players, and start-ups are joining the industry competition. Top 4 companies in the ASEAN veterinary rabies vaccines industry such as Zoetis, Merck Animal Health, Virbac, and Boehringer Ingelheim International account for approximately 35-40% of the market share. These players focus on expanding their product portfolios through innovation and advanced formulations, including inactivated and recombinant vaccines, to enhance efficacy and safety.
 

Additionally, there are several local and regional players operating in the market who are boosting competition by providing affordable options at lower costs. These players are also involved in several strategies such as mergers, acquisitions, and novel product launches to expand their product offerings.
 

ASEAN Veterinary Rabies Vaccines Market Companies

Few of the prominent players operating in the ASEAN veterinary rabies vaccines industry include:

• Brilliant Bio Pharma Limited
• Bharat Biotech
• BroadChem Philippines Biopharma Corporation
• Boehringer Ingelheim International
• Indian Immunologicals
• Komipharm International
• Merck Animal Health
• Virbac
• Zoetis
   
• Zoetis is a leading player in the animal vaccines market, offering a broad portfolio of vaccines. The company invests in R&D to develop advanced biologics and innovative vaccine technologies, strengthening its market position globally. The company has a wide range of rabies vaccine products catering to the needs of dogs, cats, ferrets, cattle and sheep 12 weeks of age or older against rabies.
   
• Boehringer Ingelheim International has a strong presence in the ASEAN veterinary rabies vaccine market with its wide regional presence and animal health product portfolio. Companion and livestock animals are provided effective rabies vaccination solutions because of the company's extensive R&D capabilities and global reach. In collaboration with veterinary professionals and governments across the ASEAN region, Boehringer Ingelheim works alongside regional stakeholders to control rabies and improve animal health and public health by reducing diseases and zoonotic risks, fulfilling ASEAN's health goals.
   

ASEAN Veterinary Rabies Vaccines Industry News

• In April 2024, Beijing Small Animal Diagnosis and Treatment Industry Association collaborated with Merck Animal Health Products (Shanghai) Co., Ltd. and Ruipai Pet Hospital to officially launch Beijing 2024 CRC Rabies Prevention and Control Project.
   
• In April 2022, Boehringer Ingelheim organized multiple rabies vaccination initiatives across Asia as part of their commitment to sustainable development. The company aims to vaccinate 12,000 animals across Malaysia, the Philippines, Indonesia, and Vietnam.
   
• In June 2024, LakeShore Biopharma Co., Ltd. announced positive results from its phase III clinical trial for the next-generation PIKA rabies vaccine. This trial aimed to fulfill the World Health Organization's (WHO) vision of a one-week vaccine regimen for rabies, replacing the conventional three- or four-week schedules.
   

The ASEAN veterinary rabies vaccines market research report includes in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 - 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Animal Type

• Companion animals
  • Dogs
  • Cats
  • Other companion animals
• Livestock animals
  • Cattle
  • Sheep and goats
  • Other livestock animals
• Wildlife

Market, By Application

• Pre exposure prophylaxis
• Post exposure prophylaxis

Market, By Route of Administration

• Oral
• Injectable

Market, By End Use

• Veterinary hospitals and clinics
• Animal shelters and rescue organizations
• Research institutes

The above information is provided for the following countries:

• Indonesia
• Vietnam
• Myanmar
• Malaysia
• Thailand
• Philippines
• Laos
• Cambodia